ECSP056029A - Formulación para un inhalador con dosis medida que emplea hidrofluoroalcanos como propulsores - Google Patents

Formulación para un inhalador con dosis medida que emplea hidrofluoroalcanos como propulsores

Info

Publication number
ECSP056029A
ECSP056029A EC2005006029A ECSP056029A ECSP056029A EC SP056029 A ECSP056029 A EC SP056029A EC 2005006029 A EC2005006029 A EC 2005006029A EC SP056029 A ECSP056029 A EC SP056029A EC SP056029 A ECSP056029 A EC SP056029A
Authority
EC
Ecuador
Prior art keywords
formulation
inhaler
hydrofluoroalcans
propulsors
dose measurement
Prior art date
Application number
EC2005006029A
Other languages
English (en)
Inventor
George Destefano
Linda Jean Kelash-Cannavo
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ECSP056029A publication Critical patent/ECSP056029A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Se describe una formulación en suspensión mejorada para uso en un inhalador con dosis medida que tiene un propulsor de hidrofluoroalcano, en donde la mejora consiste en la adición controlada de una pequeña cantidad de agua.
EC2005006029A 2003-03-20 2005-09-20 Formulación para un inhalador con dosis medida que emplea hidrofluoroalcanos como propulsores ECSP056029A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45611303P 2003-03-20 2003-03-20

Publications (1)

Publication Number Publication Date
ECSP056029A true ECSP056029A (es) 2006-01-27

Family

ID=33098086

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005006029A ECSP056029A (es) 2003-03-20 2005-09-20 Formulación para un inhalador con dosis medida que emplea hidrofluoroalcanos como propulsores

Country Status (28)

Country Link
US (1) US7914770B2 (es)
EP (1) EP1608336B1 (es)
JP (1) JP4708332B2 (es)
KR (1) KR101113003B1 (es)
CN (1) CN1761455A (es)
AT (1) ATE390125T1 (es)
AU (1) AU2004224367B2 (es)
BR (1) BRPI0408547A (es)
CA (1) CA2519523C (es)
CO (1) CO5640070A2 (es)
CY (1) CY1108137T1 (es)
DE (1) DE602004012718T2 (es)
DK (1) DK1608336T3 (es)
EA (1) EA009087B1 (es)
EC (1) ECSP056029A (es)
ES (1) ES2304616T3 (es)
HR (1) HRP20050822B1 (es)
ME (1) ME00420B (es)
MX (1) MXPA05009920A (es)
NO (1) NO336457B1 (es)
NZ (1) NZ542957A (es)
PL (1) PL1608336T3 (es)
PT (1) PT1608336E (es)
RS (1) RS51663B (es)
SI (1) SI1608336T1 (es)
UA (1) UA89751C2 (es)
WO (1) WO2004084858A2 (es)
ZA (1) ZA200506463B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004011381A1 (de) * 2004-03-05 2005-09-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Impaktionsdüse für treibgasbetriebene Dosieraerosole
EA013428B1 (ru) 2004-07-02 2010-04-30 Бёрингер Ингельхайм Интернациональ Гмбх РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА
US20060140873A1 (en) * 2004-12-27 2006-06-29 Chang Heng W Aerosol pharmaceutical compositions
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006014433A1 (de) * 2006-03-27 2007-10-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dosieraerosole für die Verabreichung von pharmazeutischen Zubereitungen
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
WO2008047239A2 (en) * 2006-09-21 2008-04-24 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
AU2008289109B2 (en) * 2007-08-17 2012-02-02 Centrexion Therapeutics Corporation High concentration local anesthetic formulations
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
WO2010019953A1 (en) 2008-08-15 2010-02-18 Arcion Therapeutics, Inc. High concentration local anesthetic formulations for treating non-neuropathic pain
EP2662472B1 (de) 2009-03-31 2019-02-27 Boehringer Ingelheim International Gmbh Verfahren zur Beschichtung einer Oberfläche eines Bauteils
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
EP2504052B1 (en) 2009-11-25 2022-07-27 Boehringer Ingelheim International GmbH Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
US20120204871A1 (en) * 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
CN102798044B (zh) * 2012-08-02 2014-09-10 深圳市华星光电技术有限公司 侧入式背光模组
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
DK3139984T3 (da) 2014-05-07 2021-07-19 Boehringer Ingelheim Int Forstøver
DK3139982T3 (da) 2014-05-07 2022-05-16 Boehringer Ingelheim Int Forstøver
WO2015169732A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Container, nebulizer and use
US20180071231A1 (en) * 2015-04-10 2018-03-15 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
GB2573297A (en) * 2018-04-30 2019-11-06 Mexichem Fluor Sa De Cv Pharmaceutical composition
US20230271770A1 (en) * 2020-04-21 2023-08-31 Amphastar Pharmaceuticals, Inc. Anti-Viral Pharmaceutical Formulations Administered Via Devices for Lung Targeted Delivery

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
GB8824804D0 (en) * 1988-10-22 1988-11-30 Fisons Plc Device
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5919435A (en) * 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
JP3009924B2 (ja) * 1992-12-09 2000-02-14 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 安定化医用エアーゾル溶液製剤
KR100304739B1 (ko) * 1993-04-30 2001-11-30 스프레이그 로버트 월터 연무식용기에사용하기위한밀봉부재
EP0708805B9 (en) 1993-07-15 2012-03-21 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
ES2214536T3 (es) * 1995-04-14 2004-09-16 Smithkline Beecham Corporation Inhalador dosificador de dipropionato de beclometasona.
GB9513084D0 (en) * 1995-06-27 1995-08-30 Bespak Plc Dispensing apparatus
SE9701750D0 (sv) * 1997-05-12 1997-05-12 Astra Pharma Prod Inhalation device and method of manufacture thereof
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
CA2338680C (en) * 1998-08-04 2008-10-14 Jago Research Ag Medicinal aerosol formulations
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6261539B1 (en) * 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US7074388B2 (en) * 1998-12-10 2006-07-11 Kos Life Science, Inc. Water stabilized medicinal aerosol formulation
US20030008369A1 (en) * 1999-03-03 2003-01-09 Board Of Regents, The University Of Texas System Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
EP1241113A1 (en) 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
US20070089735A1 (en) 2001-06-26 2007-04-26 Alan Langford Aerosol actuator

Also Published As

Publication number Publication date
NZ542957A (en) 2008-09-26
CA2519523C (en) 2012-03-13
US7914770B2 (en) 2011-03-29
EA009087B1 (ru) 2007-10-26
KR101113003B1 (ko) 2012-02-24
JP4708332B2 (ja) 2011-06-22
RS20050705A (en) 2008-04-04
EP1608336A2 (en) 2005-12-28
CN1761455A (zh) 2006-04-19
PL1608336T3 (pl) 2008-09-30
MXPA05009920A (es) 2005-11-04
ZA200506463B (en) 2006-04-26
ME00420B (me) 2011-12-20
DE602004012718T2 (de) 2009-05-07
SI1608336T1 (sl) 2008-08-31
UA89751C2 (ru) 2010-03-10
JP2006520797A (ja) 2006-09-14
NO20054839L (no) 2005-10-19
CA2519523A1 (en) 2004-10-07
CY1108137T1 (el) 2014-02-12
HRP20050822A2 (en) 2006-10-31
ES2304616T3 (es) 2008-10-16
KR20050111382A (ko) 2005-11-24
US20040184994A1 (en) 2004-09-23
DK1608336T3 (da) 2008-06-02
EA200501363A1 (ru) 2006-04-28
CO5640070A2 (es) 2006-05-31
AU2004224367B2 (en) 2009-10-08
EP1608336B1 (en) 2008-03-26
RS51663B (en) 2011-10-31
ATE390125T1 (de) 2008-04-15
WO2004084858A2 (en) 2004-10-07
PT1608336E (pt) 2008-04-21
NO336457B1 (no) 2015-08-31
BRPI0408547A (pt) 2006-03-07
AU2004224367A1 (en) 2004-10-07
DE602004012718D1 (de) 2008-05-08
WO2004084858A3 (en) 2004-11-04
HRP20050822B1 (hr) 2013-09-30

Similar Documents

Publication Publication Date Title
ECSP056029A (es) Formulación para un inhalador con dosis medida que emplea hidrofluoroalcanos como propulsores
AR110174A2 (es) Agentes endoparasiticidas y procedimiento de preparación
CO6680609A2 (es) Composición acuosa que contiene bromhexina
UY30314A1 (es) Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmacéuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
CR10088A (es) Compuestos de piperazina con accion herbicida
ECSP109852A (es) Uso de homo y copolímeros para la estabilización de formulaciones de principios activos
ECSP045491A (es) Nueva sal formiato de o-desmetil venlafaxina
CR8986A (es) Isoxazoles sustituidos como fungicidas
AR055319A1 (es) Derivados de isoquinoleina, composiciones farmaceuticas y usos
CL2007001391A1 (es) Compuestos derivados de pirrolidinas sustituidas, inhibidores del factor xa y/o inhibidores sobre la serina proteasa; composicion farmaceutica que comprende a dichos compuestos; proedimiento para preparar la composicon farmaceutica; y uso de los compuestos preparar un medicamneto con un efecto antitrombotico
CR9786A (es) Compuestos de bencimidazol-tiofeno
ECSP088584A (es) Nuevos derivados de benzimidazol como inhibidores del receptor vanilloide 1 (vrl)
PA8577201A1 (es) 3-fenil-propionamido, 3-fenil-acrilamido y derivados 3-fenil-propinamido como inhibidores de mao-b
CO2022009510A2 (es) Compuestos activos frente a receptores nucleares
UY38540A (es) Compuestos de fenilamidina 3-sustituida, preparación y uso
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
AR064219A1 (es) Cuerpo moldeado que contiene titanio
ECSP034541A (es) Formulacion de una solucion de inhalacion con una sal tiotropio
ECSP088219A (es) Nueva sal i
ECSP077378A (es) Isoxazoles sustituidos como fungicidas
AR043769A1 (es) Espuma de polimero con rendimiento mejorado frente al fuego
CL2008001722A1 (es) Compuestos derivados de heterociclos; agente que contiene a dichos compuestos, diluyentes y/o sustancias tensoactivas; procedimiento para combatir organismos nocivos; y uso de dichos compuestos para combatir organismos nocivos.
BRPI0803040A2 (pt) sistema de estêncil, e, método para usar um sistema de estêncil
CR7484A (es) Triazolopirimidas funguicidas, procedimientos para su obtencion y el uso de las mismas para combatir hongos nocivos, asi como productos que las contienen